SCHEMBL1376749

SCHEMBL1376749

COc1cc(-c2cc(CNc3ccc(-c4nc[nH]n4)cc3)cn2S(=O)(=O)c2ccc(C)cc2)cc(OC)c1OC

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.37
ACVR1 Q04771 1/20 0.37
LMNA P02545 2/20 0.36
HPGD P15428 1/20 0.36
TUBB4A P04350 1/20 0.36
TUBB P07437 1/20 0.36
TUBA3C P0DPH7 1/20 0.36
TUBA1B P68363 1/20 0.36
TUBA4A P68366 1/20 0.36
TUBB4B P68371 1/20 0.36
TUBB3 Q13509 1/20 0.36
TUBB2A Q13885 1/20 0.36
TUBB8 Q3ZCM7 1/20 0.36
TUBA3E Q6PEY2 1/20 0.36
TUBA1A Q71U36 1/20 0.36
TUBA1C Q9BQE3 1/20 0.36
TUBB6 Q9BUF5 1/20 0.36
TUBB2B Q9BVA1 1/20 0.36
TUBB1 Q9H4B7 1/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3367765 0.85 TUBB4A (0.38) MAPTLMNATUBB4ATUBBTUBA3C
SCHEMBL1380044 0.82 ACVR1 (0.40) MAPTACVR1LMNATUBB4ATUBB
SCHEMBL1377862 0.80 MAPT (0.53) MAPTACVR1LMNAHPGDMEN1
SCHEMBL3372538 0.73 RAB9A (0.55) MAPTACVR1LMNAHPGDTUBB4A
SCHEMBL3371527 0.71 HTR6 (0.42) ACVR1MEN1KMT2A
SCHEMBL3367690 0.71 CA1 (0.43) MAPTLMNATUBB4ATUBBTUBA3C
SCHEMBL1376420 0.69 CA2 (0.61) MAPTLMNAMEN1GAAKMT2A
SCHEMBL3368043 0.69 TUBB4A (0.44) MAPTLMNATUBB4ATUBBTUBA3C
SCHEMBL1376747 0.68 PGR (0.36) MAPTLMNAHPGDMEN1GAA
SCHEMBL1379606 0.68 MAP3K11 (0.48) TUBB4ATUBBTUBA3CTUBA1BTUBA4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4716996-B2 2011-07-06 JP claimed
EP-1628957-B1 SULFOPYRROLES TAKEDA PHARMACEUTICAL (JP) 2010-09-29 EP claimed
US-7612064-B2 Sulfopyrroles TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2009-11-03 US claimed
US-20070060570-A1 Sulfopyrroles TALEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-03-15 US claimed
EP-1628957-A1 SULFOPYRROLES Takeda Pharmaceutical Company Limited (JP) 2006-03-01 EP claimed
WO-2004103968-A1 SULFOPYRROLES APONETICS AG (CH) 2004-12-02 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070060570-A1 Sulfopyrroles TYK2, ARSA, SULT2A1 MAPT 4766/4885ACVR1 1845/4885LMNA 4097/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.